Braslyn Ltd.
Follow13F filer, CIK 1642355, NEW PROVIDENCE, Bahamas
Braslyn Ltd. reported $2,346,222 across 2 holdings for the quarter ended 2024-03-31, in a 13F-HR filed 2024-05-15.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000895345-24-000184
- Period
- 2024-03-31
- Reported value
- $2.35M
- Holdings
- 2
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 1
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| MIRATI THERAPEUTICS INCexited | -3,135,966 | -$184M |
| INSEEGO CORPreduced | -6,853,347 | -$19.2M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q1 2024
Share positions as resolved from 13F-HR 0000895345-24-000184, largest first. % of portfolio is the value over $2,346,222, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| INSEEGO CORPINSEEGO CORP | 761,483 | $2.13M | 90.88% | -6,853,347 | |||
| TNGXTANGO THERAPEUTICS INC | 26,961 | $214K | 9.12% | 0 | Timeline |
Sold out in Q1 2024
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INC | 3,135,966 | $184M | shares |
How Q1 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000895345-24-000184 | base | 2024-05-15 | acceptance time not in the bulk data set |